Prognosis-related microRNAs in esophageal cancer

Bibliography

• Varghese TK Jr, Hofstetter WL, Rizk NP, et al. The society of thoracic surgeons guidelines on the diagnosis and staging of patients with esophageal cancer. Ann Thorac Surg 2013;96(1):346-56
   PubMed Web of Science ®Google Scholar
• Hong L, Han Y, Lu Q, et al. Drug resistance-related microRNAs in esophageal cancer. Expert Opin Biol Ther 2012;12:1487-94
   PubMed Web of Science ®Google Scholar
• Lagergren J, Lagergren P. Recent developments in esophageal adenocarcinoma. CA Cancer J Clin 2013;63:232-48
   PubMed Web of Science ®Google Scholar
• Hong L, Li S, Han Y, et al. Angiogenesis-related molecular targets in esophageal cancer. Expert Opin Investig Drugs 2011;20:637-44
   PubMed Web of Science ®Google Scholar
• Nieman DR, Peters JH. Treatment strategies for esophageal cancer. Gastroenterol Clin North Am 2013;42(1):187-97
   PubMed Web of Science ®Google Scholar
• Di Leva G, Croce CM. miRNA profiling of cancer. Curr Opin Genet Dev 2013;23:3-11
   PubMed Web of Science ®Google Scholar
• Hong L, Han Y, Li S, et al. The malignant phenotype-associated microRNA in gastroenteric, hepatobiliary and pancreatic carcinomas. Expert Opin Biol Ther 2010;10:1693-701
   PubMed Web of Science ®Google Scholar
• Yates LA, Norbury CJ, Gilbert RJ. The long and short of microRNA. Cell 2013;153:516-19
   PubMed Web of Science ®Google Scholar
• Hong L, Yang Z, Ma J, Fan D. Function of miRNA in controlling drug resistance of human cancers. Curr Drug Targets 2013;14:1118-27
   PubMed Web of Science ®Google Scholar
• Pencheva N, Tavazoie SF. Control of metastatic progression by microRNA regulatory networks. Nat Cell Biol 2013;15:546-54
   PubMed Web of Science ®Google Scholar
• Aguda BD. Modeling microRNA-transcription factor networks in cancer. Adv Exp Med Biol 2013;774:149-67
   PubMed Web of Science ®Google Scholar
• Hong L, Han Y, Zhou Y, Nita A. Angiogenesis-related microRNAs in colon cancer. Expert Opin Biol Ther 2013;13:77-84
   PubMed Web of Science ®Google Scholar
• Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res 2012;110(3):483-95
   PubMed Web of Science ®Google Scholar
• Qu H, Xu W, Huang Y, Yang S. Circulating miRNAs: promising biomarkers of human cancer. Asian Pac J Cancer Prev 2011;12(5):1117-25
   PubMed Web of Science ®Google Scholar
• Grady WM, Tewari M. The next thing in prognostic molecular markers: microRNA signatures of cancer. Gut 2010;59(6):706-8
   PubMed Web of Science ®Google Scholar
• Mulligan CR Jr. Multidisciplinary management of esophageal cancer. Surg Oncol Clin N Am 2013;22(2):217-46
   PubMed Web of Science ®Google Scholar
• Hong L, Han Y, Zhang Y, et al. MicroRNA-21: a therapeutic target for reversing drug resistance in cancer. Expert Opin Ther Targets 2013;17:1073-80
   PubMed Web of Science ®Google Scholar
• Zhao Y, Schetter AJ, Yang GB, et al. microRNA and inflammatory gene expression as prognostic marker for overall survival in esophageal squamous cell carcinoma. Int J Cancer 2013;132(12):2901-9
   PubMed Web of Science ®Google Scholar
• Mathé EA, Nguyen GH, Bowman ED, et al. MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res 2009;15(19):6192-200
   PubMed Web of Science ®Google Scholar
• Nouraee N, Van Roosbroeck K, Vasei M, et al. Expression, tissue distribution and function of miR-21 in esophageal squamous cell carcinoma. PLoS One 2013;8(9):e73009
   PubMed Web of Science ®Google Scholar
• Han HS, Yun J, Lim SN, et al. Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion. Int J Cancer 2013;133(3):645-52
   PubMed Web of Science ®Google Scholar
• Qi B, Yao WJ, Zhao BS, et al. Involvement of MicroRNA-198 overexpression in the poor prognosis of esophageal cancer. Asian Pac J Cancer Prev 2013;14(9):5073-6
   PubMed Web of Science ®Google Scholar
• Guo Y, Chen Z, Zhang L, et al. Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res 2008;68(1):26-33
   PubMed Web of Science ®Google Scholar
• Feber A, Xi L, Luketich JD, et al. MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg 2008;135(2):255-60
   PubMed Web of Science ®Google Scholar
• Hong L, Han Y, Zhang H, et al. The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma. Ann Surg 2010;251:1056-63
   PubMed Web of Science ®Google Scholar
• Yokobori T, Suzuki S, Tanaka N, et al. MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1. Cancer Sci 2013;104(1):48-54
   PubMed Web of Science ®Google Scholar
• Patterson EE, Holloway AK, Weng J, et al. MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy. Cancer 2011;117(8):1630-9
   PubMed Web of Science ®Google Scholar
• Penna E, Orso F, Cimino D, et al. miR-214 coordinates melanoma progression by upregulating ALCAM through TFAP2 and miR-148b downmodulation. Cancer Res 2013;73(13):4098-111
   PubMed Web of Science ®Google Scholar
• Zhou Y, Hong L. Prediction value of miR-483 and miR-214 in prognosis and multidrug resistance of esophageal squamous cell carcinoma. Genet Test Mol Biomarkers 2013;17:470-4
   PubMed Web of Science ®Google Scholar
• Li J, Li X, Li Y, et al. Cell-specific detection of miR-375 downregulation for predicting the prognosis of esophageal squamous cell carcinoma by miRNA in situ hybridization. PLoS One 2013;8(1):e53582
   PubMedGoogle Scholar
• Nguyen GH, Schetter AJ, Chou DB, et al. Inflammatory and microRNA gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma. Clin Cancer Res 2010;16(23):5824-34
   PubMed Web of Science ®Google Scholar
• Lin RJ, Xiao DW, Liao LD, et al. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma. J Surg Oncol 2012;105(2):175-82
   PubMed Web of Science ®Google Scholar
• Hu Y, Correa AM, Hoque A, et al. Prognostic significance of differentially expressed miRNAs in esophageal cancer. Int J Cancer 2011;128(1):132-43
   PubMed Web of Science ®Google Scholar
• Hamano R, Miyata H, Yamasaki M, et al. Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway. Clin Cancer Res 2011;17(9):3029-38
   PubMed Web of Science ®Google Scholar
• Tanaka K, Miyata H, Yamasaki M, et al. Circulating miR-200c levels significantly predict response to chemotherapy and prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer. Ann Surg Oncol 2013;20:607-15
   PubMedGoogle Scholar
• Takeshita N, Hoshino I, Mori M, et al. Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma. Br J Cancer 2013;108(3):644-52
   PubMed Web of Science ®Google Scholar
• Alder H, Taccioli C, Chen H, et al. Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer. Carcinogenesis 2012;33(9):1736-44
   PubMed Web of Science ®Google Scholar
• Li X, Lin R, Li J. Epigenetic silencing of microRNA-375 regulates PDK1 expression in esophageal cancer. Dig Dis Sci 2011;56(10):2849-56
   PubMed Web of Science ®Google Scholar
• Komatsu S, Ichikawa D, Takeshita H, et al. Prognostic impact of circulating miR-21 and miR-375 in plasma of patients with esophageal squamous cell carcinoma. Expert Opin Biol Ther 2012;12(Suppl 1):S53-9
   PubMed Web of Science ®Google Scholar
• Komatsu S, Ichikawa D, Takeshita H, et al. Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer 2011;105(1):104-11
   PubMed Web of Science ®Google Scholar
• Zhang T, Wang Q, Zhao D, et al. The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma. Clin Sci (Lond) 2011;121(10):437-47
   PubMed Web of Science ®Google Scholar
• Hirajima S, Komatsu S, Ichikawa D, et al. Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer 2013;108(9):1822-9
   PubMed Web of Science ®Google Scholar
• Gu J, Wang Y, Wu X. MicroRNA in the pathogenesis and prognosis of esophageal cancer. Curr Pharm Des 2013;19(7):1292-300
   PubMed Web of Science ®Google Scholar
• Fassan M, Baffa R, Kiss A, et al. MicroRNA dysregulation in esophageal neoplasia: the biological rationale for novel therapeutic options. Curr Pharm Des 2013;19(7):1236-41
   PubMed Web of Science ®Google Scholar
• Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 2010;101(10):2087-92
   PubMed Web of Science ®Google Scholar
• Zheng S, Vuitton L, Sheyhidin I, et al. Northwestern China: a place to learn more on oesophageal cancer. Part two: gene alterations and polymorphisms. Eur J Gastroenterol Hepatol 2011;23(12):1087-99
   PubMed Web of Science ®Google Scholar